✦ LIBER ✦

Complementary and alternative medicine use in patients presenting to a head and neck oncology clinic

✍ Scribed by Tarren Vyas; Robert D. Hart; Jonathan R. Trites; Timothy J. Philips; Kathleen E. M. Archibald; Judith E. Phillips; S. Mark Taylor

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 307 KB
Volume: 32
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.21255

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

The aim of this study was to determine the prevalence of complementary and alternative medicine (CAM) use among patients presenting to a head and neck oncology clinic prior to a diagnosis.

Methods

The study was conducted by administering questionnaires to 102 patients after being seen in the Head and Neck Oncology clinic for their initial consultation. The questionnaire assessed the extent of CAM use, types of CAMs used, and their reasons for use.

Results

A total of 132 CAMs were currently being used among 56 patients. The most common CAMs in use were multivitamins (26/132) and vitamin D (21/132). Meditation and yoga were associated with the greatest perceived benefit. The majority of patients obtained their information from family and friends. Most patients were using CAMs for physical health and well‐being.

Conclusion

📜 SIMILAR VOLUMES

Importance of patient examination to cli

Importance of patient examination to clinical quality assurance in head and neck radiation oncology

✍ David I. Rosenthal; Joshua A. Asper; Jerry L. Barker Jr.; Adam S. Garden; K. S. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## Abstract ## Background. When quality assurance programs in clinical radiation oncology focus mainly on the technical aspects of treatment, they tend to underplay questions of therapeutic process and outcome. We determined the value of clinical peer review in radiation therapy for head and neck

Reply to Emotional Well-Being Does Not P

Reply to Emotional Well-Being Does Not Predict Survival in Head and Neck Cancer Patients : A Radiation Therapy Oncology Group study

✍ James C. Coyne; Thomas F. Pajak; Deborah Watkins Bruner 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 1 views

A Radiation Therapy Oncology Group Study I n their recent article, Coyne et al. 1 vastly overstated the quality of their study and the meaning of their findings. ## Poor Measurement They used only 4 items from an Emotional Well-Being subscale, which hardly constitutes a reliable assessment of dep

The use of granulocyte colony stimulatin

The use of granulocyte colony stimulating factor to promote wound healing in a neutropenic patient after head and neck surgery

✍ D. Thane Cody II; Gerry F. Funk; David Wagner; Paul W. Gidley; Scott M. Graham; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 2 views

## Background: Neutropenia and neutrophil dysfunction, in association with a variety of diseases, has been shown to play a role in poor wound healing. wound breakdown with fistula formation in patients undergoing total laryngectomy results in significant morbidity and increased hospital stay. altho

Long-term survival data and prognostic f

Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: A hellenic co-operative oncology group study

✍ Fountzilas, George ;Kosmidis, Paris ;Avramidis, Vasilios ;Nikolaou, Angelos ;Kal 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

A group of 154 patients with locally advanced head and neck cancer, treated with platinum-based induction chemotherapy, were followed up for 5 years and several pretreatment characteristics were analyzed for possible correlation to a complete response (CR) to chemotherapy, time to progression (TTP)

High rate of clinical complete response

High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin

✍ Jin-Ching Lin; Jian-Sheng Jan; Chen-Yi Hsu; Daniel Yong-Kie Wong 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

A Phase II trial was initiated to evaluate the response to and toxicity of a new regimen of weekly outpatient neoadjuvant chemotherapy in patients with oral carcinoma. ## METHODS. Patients with previously untreated squamous cell carcinoma of the oral cavity were eligible for this trial. The neoad